Profile data is unavailable for this security.
About the company
Nyrada Inc. is a preclinical stage, drug development company specializing in small molecule drugs to treat cardiovascular and neurological diseases. The Company’s two lead programs are focused on cholesterol-lowering and brain injury. These programs are developing an oral, small molecule cholesterol-lowering drug, and a drug to reduce secondary brain damage following a stroke or traumatic brain injury (TBI). Its Cholesterol-Lowering Program is an oral PCSK9 inhibitor for the treatment of high blood LDL-cholesterol levels in patients poorly responsive to or unable to take statin drugs. Its Brain Injury Program is developing a drug to block secondary brain damage that occurs following a stroke or TBI, such as severe head trauma from contact sports, a fall, or a motor vehicle accident. The Brain Injury Program is a neuroprotectant drug to reduce the impact of long-term disability in patients who suffer a traumatic brain injury or ischemic stroke. It is also developing new therapies.
- Revenue in AUD (TTM)3.40m
- Net income in AUD-1.39m
- Incorporated2017
- Employees--
- LocationNyrada IncSuite 2, Level 3,, 828 Pacific HighwayGORDON 2072AustraliaAUS
- Phone+61 29498-3390
- Fax+61 29053-1999
- Websitehttps://www.nyrada.com/site/content/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hydration Pharmaceuticals Co Ltd | 14.92m | -11.81m | 5.18m | -- | -- | -- | -- | 0.3474 | -0.0472 | -0.0472 | 0.056 | -0.0139 | 1.49 | 1.56 | 6.38 | -- | -117.74 | -79.98 | -251.39 | -111.57 | 56.00 | 48.73 | -79.18 | -99.53 | 0.8282 | -4.39 | 2.42 | -- | 10.34 | 19.27 | 23.61 | -- | -- | -- |
| Nutritional Growth Solutions Ltd | 4.17m | -4.14m | 5.82m | -- | -- | -- | -- | 1.40 | -0.1712 | -0.1712 | 0.1722 | -0.0877 | 2.08 | 2.36 | 33.46 | -- | -206.84 | -- | -- | -- | 22.36 | 42.47 | -99.30 | -152.30 | 0.0943 | -57.50 | -- | -- | 1.26 | 41.61 | 31.91 | -- | -- | -- |
| TrivarX Ltd | 893.31k | -1.43m | 6.86m | 4.00 | -- | 0.6211 | -- | 7.67 | -0.0045 | -0.0045 | 0.0027 | 0.0242 | 0.0935 | -- | -- | -- | -15.02 | -37.57 | -17.67 | -43.65 | 100.00 | 92.56 | -160.59 | -446.23 | -- | -105.74 | 0.0016 | -- | -6.99 | -26.39 | 53.28 | -- | 17.61 | -- |
| Epsilon Healthcare Ltd | 7.21m | -5.93m | 7.21m | -- | -- | 0.7868 | -- | 0.9994 | -0.0198 | -0.0198 | 0.0241 | 0.0305 | 0.3839 | 17.94 | 2.73 | -- | -31.54 | -35.68 | -46.30 | -41.11 | 37.99 | 26.88 | -82.17 | -197.56 | 0.5237 | -9.28 | 0.2329 | -- | 29.36 | 30.99 | -43.77 | -- | 8.14 | -- |
| Firebrick Pharma Ltd | 14.52k | -1.18m | 10.93m | -- | -- | 4.33 | -- | 752.45 | -0.0066 | -0.0066 | 0.00008 | 0.012 | 0.0054 | -- | 0.0267 | -- | -43.64 | -98.70 | -51.22 | -109.33 | -156.89 | -- | -8,098.28 | -80,697.28 | 6.36 | -- | 0.00 | -- | 1,649.40 | -- | 82.71 | -- | -- | -- |
| Anatara Lifesciences Ltd | 0.00 | -1.45m | 11.19m | -- | -- | 8.12 | -- | -- | -0.0098 | -0.0098 | 0.00 | 0.0071 | 0.00 | -- | -- | -- | -93.91 | -76.37 | -126.61 | -88.90 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 28.27 | -- | -- | -- |
| Argent BioPharma Ltd | 891.08k | -17.53m | 12.48m | -- | -- | -- | -- | 14.01 | -0.5116 | -0.5116 | 0.0241 | -0.1138 | 0.0858 | 0.6144 | 1.77 | -- | -168.97 | -129.61 | -- | -254.28 | 22.86 | -27.15 | -1,969.34 | -667.99 | 0.1532 | -37.54 | -- | -- | -73.70 | 6.31 | 15.81 | -- | -17.96 | -- |
| Acrux Ltd | 8.10m | -5.80m | 13.37m | 43.00 | -- | 4.08 | -- | 1.65 | -0.02 | -0.02 | 0.028 | 0.0113 | 0.728 | -- | 2.61 | -- | -52.14 | -45.05 | -71.89 | -54.04 | 51.14 | -- | -71.62 | -114.01 | -- | -- | 0.5307 | -- | -32.11 | 8.91 | -659.16 | -- | -6.20 | -- |
| Althea Group Holdings Ltd | 30.37m | -32.06m | 16.21m | -- | -- | 51.78 | -- | 0.5338 | -0.0858 | -0.0858 | 0.0808 | 0.0008 | 0.8438 | 2.34 | 7.03 | -- | -89.06 | -37.78 | -167.97 | -47.13 | 60.70 | 53.83 | -105.54 | -94.47 | 0.4086 | -4.08 | 0.9466 | -- | 20.87 | 99.01 | -133.57 | -- | -25.27 | -- |
| Immuron Ltd | 4.90m | -6.94m | 17.19m | 6.00 | -- | 1.35 | -- | 3.51 | -0.0304 | -0.0304 | 0.0215 | 0.0557 | 0.2612 | 1.29 | 5.43 | -- | -36.96 | -27.01 | -42.53 | -29.33 | 68.06 | 74.23 | -141.49 | -245.53 | 4.87 | -3.03 | 0.0032 | -- | 171.67 | 15.48 | -83.20 | -- | -37.22 | -- |
| Calmer Co International Ltd | 4.26m | -3.73m | 17.64m | -- | -- | -- | -- | 4.14 | -0.0035 | -0.0035 | 0.0038 | -0.0003 | 1.13 | 2.01 | 9.14 | -- | -98.45 | -119.20 | -395.42 | -195.49 | 49.62 | 39.01 | -87.42 | -219.69 | 0.5607 | -12.30 | 1.27 | -- | 138.92 | 87.79 | 28.91 | -- | -20.42 | -- |
| Nyrada Inc | 3.40m | -1.39m | 22.01m | -- | -- | 3.79 | -- | 6.47 | -0.0081 | -0.0081 | 0.0209 | 0.0277 | 0.6147 | -- | -- | -- | -25.13 | -53.28 | -29.75 | -62.52 | -- | -- | -40.89 | -236.15 | -- | -- | 0.00 | -- | 115.55 | 46.42 | 82.12 | -- | -- | -- |
| Oncosil Medical Ltd | 583.20k | -11.91m | 31.32m | 2.00 | -- | 4.92 | -- | 53.70 | -0.0054 | -0.0054 | 0.0003 | 0.0014 | 0.0641 | -- | 3.12 | -- | -130.97 | -67.66 | -162.31 | -77.45 | -158.87 | -- | -2,042.81 | -768.23 | -- | -- | 0.0147 | -- | 35.54 | -31.37 | -5.03 | -- | 67.76 | -- |
